SW
SIOX

SVB Wealth’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

SVB Wealth’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-94,150
Closed -$26K – 1107
2022
Q3 		$26K Buy
+94,150
New +$32.3K ﹤0.01% 970

Other funds holding SIOX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $195M AUM 29.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SVB Wealth's SIOX Position: Q4 2022 in Review

SVB Wealth sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2022, closing a stake of 94,150 shares — an estimated $26K sold.

SVB Wealth first reported a position in SIOX in Q3 2022 and held it in 1 quarter. The position peaked at $26K in Q3 2022. 37 funds tracked by Wall St. Rank hold SIOX as of Q4 2022.

  • SVB Wealth reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • SVB Wealth sold 94,150 Sio Gene Therapies Inc. Common Stock shares in Q4 2022, an estimated $26K.
  • SVB Wealth first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • SVB Wealth's Sio Gene Therapies Inc. Common Stock position peaked at $26K in Q3 2022.
  • 37 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2022.

Based on SVB Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.